American Alpha Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$497K Sell
1,180
-659
-36% -$263K 0.26% 69
2026
Q2
$666K Buy
1,839
+27
+1% +$9.24K 0.36% 46
2026
Q1
$638K Buy
1,812
+72
+4% +$25.7K 0.34% 50
2025
Q4
$570K Buy
1,740
+271
+18% +$86K 0.34% 53
2025
Q3
$415K Sell
1,469
-30
-2% -$8.7K 0.29% 61
2025
Q2
$419K Buy
1,499
+140
+10% +$39.7K 0.33% 62
2025
Q1
$423K Buy
+1,359
New +$401K 0.36% 54

Other funds holding AMGN

American Alpha Advisors's AMGN Position: Q3 2026 in Review

American Alpha Advisors reduced its Amgen (AMGN) stake by 36% in Q3 2026, selling an estimated $263K and leaving 1,180 shares worth $497K. The position accounts for 0.26% of the portfolio, ranked #69.

American Alpha Advisors first reported a position in AMGN in Q1 2025 and has held it in 7 quarters since. The position peaked at $666K in Q2 2026. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • American Alpha Advisors held 1,180 shares of Amgen worth $497K as of Q3 2026.
  • American Alpha Advisors sold 659 Amgen shares in Q3 2026, an estimated $263K.
  • Amgen made up 0.26% of American Alpha Advisors's portfolio in Q3 2026, its #69 holding.
  • American Alpha Advisors first reported a position in Amgen in Q1 2025 and has held it in 7 quarters since.
  • American Alpha Advisors's Amgen position peaked at $666K in Q2 2026.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on American Alpha Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.